Minimally invasive (MI) caries management has largely evolved over the years to include approaches that not only aimed to preserve as much tooth structure as possible but also to embrace prevention and risk management strategies. The atraumatic restorative treatment (ART) is a minimally invasive approach that was initially established to address the issue of increasing number of salvable teeth that kept being extracted in remote parts of the world where there was a limited access to the necessary equipment to enable preserving teeth in the primary and permanent dentitions. Managing carious lesions following ART is not as demanding as that in the conventional restorative methods, however, there are certain factors known to contribute to the failure of atraumatic restorative treatment that need to be considered to ensure success. However, and despite the advantages associated with using ART there seems to be a lack of awareness among dental practitioners regarding adopting this approach that can largely affect effective practice. Therefore, there is a need to spread the awareness and further educate practitioners particularly in this Covid-19 era where the virus and its variants have impacted the provision of routine dental treatment and will continue to do so for the foreseeable future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.